{"filings":[{"id":99249,"accession_number":"0001193125-26-197278","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-04-30T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"HCA Inc. issues $3B in senior notes across three tranches maturing 2031-2036","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $1B of 4.700% notes due 2031, $750M of 5.000% notes due 2033, and $1.25B of 5.300% notes due 2036.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by parent HCA Healthcare on a senior unsecured basis.","Underwriting agreement signed April 27, 2026 with Citigroup, Barclays, BofA Securities, and J.P. Morgan as representatives.","Interest payable semi-annually on May 15 and Nov 15, beginning Nov 15, 2026.","Change-of-control put at 101% of principal plus accrued interest if accompanied by a qualifying ratings downgrade."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99248,"accession_number":"0001193125-26-187155","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-04-28T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"HCA Healthcare shareholders re-elect all nine director nominees; reject two shareholder proposals at 2026 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All nine director nominees elected; votes for ranged from 173.1M (DeParle) to 193.7M (Hazen) shares.","Ratification of Ernst & Young as independent auditor for FY2026 passed with 192.7M for, 17.0M against.","Non-binding advisory vote on named executive officer compensation approved with 182.4M for, 12.8M against.","Shareholder proposal on healthcare consequences report rejected: 21.2M for, 173.3M against.","Shareholder proposal on right to act by written consent rejected: 42.8M for, 152.1M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99247,"accession_number":"0001193125-26-182265","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-04-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Inc. proposes senior notes offering; to redeem $2.5B in near-term notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["HCA Inc. proposes public offering of senior notes; terms not yet set.","Net proceeds to be used for general corporate purposes, including repayment of commercial paper and redemption of notes.","HCA Inc. to redeem $1.5B of 5.250% notes due June 2026 and $1.0B of 5.375% notes due Sept 2026.","Redemption conditioned on receipt of net proceeds from offering; redemption date May 27, 2026.","Joint book-running managers: Citigroup, Barclays, BofA, J.P. Morgan."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99246,"accession_number":"0001193125-26-174933","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-04-24T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q1 revenue up 4.3% to $19.1B; EPS rises 10.9% to $7.15; declares $0.78 dividend","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenues $19.109B, net income $1.620B (+0.6% YoY); diluted EPS $7.15 (+10.9% YoY).","Adjusted EBITDA $3.802B (+1.9%); cash from operations $2.014B (+22.0%).","Same facility admissions +0.9%; equivalent admissions +1.3% vs Q1 2025.","Quarterly cash dividend of $0.78 per share declared, payable June 30, 2026 to holders of record June 16, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":7.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":19109000000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115130,"accession_number":"0001193125-26-071880","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HCA sets 2026 exec comp: CEO target 175% of salary; board member Dennis to retire","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Samuel Hazen target award 175% of base; CFO/COO 125%; other named execs 100%.","Awards weighted 80% on EBITDA, 20% on quality metrics (HAIs, mortality, care experience).","EBITDA payout ranges from 25% (threshold) to 200% (max); quality payout 0% if EBITDA below 90% of target.","Director Robert J. Dennis to retire at April 23, 2026 annual meeting, not standing for re-election.","Awards subject to recoupment under company policy and discretionary recoupment clauses."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115129,"accession_number":"0001193125-26-023323","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2026-01-27T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q4 EPS $8.14 (up 44.6%), revenue $19.5B, $10B buyback authorized","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $19.513B (+6.7% YoY); net income $1.878B (+30.6%); adjusted EBITDA $4.114B (+10.8%).","Diluted EPS $8.14 (+44.6%), adjusted EPS $8.01 (+28.8%); same-facility admissions +2.4%, equivalent admissions +2.5%.","Board authorized new $10B share repurchase program; $750M remained under prior authorization as of Dec 31.","Quarterly dividend raised to $0.78/share, payable March 31, 2026 to holders of record March 17.","2026 guidance: revenue $76.5B-$80B, EPS $29.10-$31.50, adjusted EBITDA $15.55B-$16.45B."],"consensus_eps_estimate":null,"consensus_eps_actual":28.33,"consensus_revenue_estimate":null,"consensus_revenue_actual":75600000000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131539,"accession_number":"0001193125-25-260809","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-10-31T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"HCA issues $3.25B senior notes: 4.30% 2030, 4.60% 2032, 4.90% 2035, 5.70% 2055","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$500M 4.30% notes due 2030, $1B 4.60% due 2032, $1B 4.90% due 2035, $750M 5.70% due 2055.","Interest payable semi-annually May 15 and Nov 15, beginning May 15, 2026.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by HCA Healthcare.","Rank equally with existing senior debt; effectively subordinated to secured debt and structurally subordinated to subsidiary liabilities.","Underwriting led by J.P. Morgan, Citigroup, Mizuho, and Wells Fargo; redemption and change-of-control put at 101%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131538,"accession_number":"0001193125-25-251612","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-10-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA subsidiary proposes senior notes offering, plans to redeem $1.5B 5.875% notes due 2026","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["HCA Inc. proposes public offering of senior unsecured notes; terms (maturity, rate, amount) to be set at pricing.","Net proceeds to be used for general corporate purposes, including repayment of $4B commercial paper program and potential redemption of $1.5B 5.875% notes due 2026.","HCA Inc. provides notice of redemption of all $1.5B 5.875% senior notes due 2026, conditioned on receipt of offering proceeds; redemption date Nov 26, 2025.","Joint book-running managers: J.P. Morgan, Citigroup, Mizuho, Wells Fargo.","Offering is made under effective shelf registration statement; copies of preliminary prospectus available from managers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":131537,"accession_number":"0001193125-25-249345","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q3 EPS $6.96, revenue $19.2B, raises 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Diluted EPS $6.96 (up 42.6% YoY); net income $1.643B (up 29.4%).","Revenue $19.161B (+9.6% YoY); Adjusted EBITDA $3.870B (+18.5%).","Same facility admissions +2.1%, same facility equivalent admissions +2.4%.","Quarterly dividend declared: $0.72/share, payable Dec 29 to holders of record Dec 15.","Full-year 2025 guidance raised (specific figures not released)."],"consensus_eps_estimate":null,"consensus_eps_actual":20.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":56087000000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148112,"accession_number":"0000950170-25-098578","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q2 revenue $18.6B (+6.4%), EPS $6.83 (+23.5%); raises 2025 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $18.605B (+6.4% YoY); net income $1.653B (+13.1% YoY).","Diluted EPS $6.83 (+23.5%); adjusted diluted EPS $6.84 (+24.4%).","Adjusted EBITDA $3.849B (+8.4%); same facility admissions +1.8%.","Quarterly cash dividend declared at $0.72/share, payable Sep 30, record Sep 16.","Company announces it is raising full-year 2025 guidance (specific new figures not provided in filing excerpt)."],"consensus_eps_estimate":null,"consensus_eps_actual":13.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":36926000000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148111,"accession_number":"0001193125-25-158208","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-07-11T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HCA Healthcare appoints John W. Chidsey, III as independent director, effective July 15","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board expands from 9 to 10 directors; Chidsey will serve on Audit & Compliance, Compensation, and Patient Safety & Quality of Care committees.","Chidsey most recently served as global CEO of Subway; previously CEO of Burger King Holdings and senior roles at Cendant and PepsiCo.","He currently serves on the board of Norwegian Cruise Line Holdings, and previously served on boards of Encompass Health, Burger King, and Brinker International.","Appointment fills a newly created directorship per the company's amended certificate of incorporation; no arrangements with any other person."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166868,"accession_number":"0001193125-25-138463","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["2.03","8.01"],"status":"ready","headline":"HCA Inc. establishes $4B commercial paper program, guaranteed by HCA Healthcare","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issuer HCA Inc. can issue up to $4B in unsecured commercial paper notes with maturities up to 397 days.","Notes unconditionally guaranteed by parent HCA Healthcare, Inc.","Proceeds used for general corporate purposes; amounts may be borrowed, repaid, and reborrowed.","Notes sold privately in U.S. commercial paper market, not registered under Securities Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166867,"accession_number":"0001193125-25-103953","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-04-29T23:59:59+00:00","items":["5.02","5.07","5.03","9.01"],"status":"ready","headline":"HCA stockholders OK 13.15M share increase for equity plan; officer exculpation amendment passed","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved First Amendment to 2020 Stock Incentive Plan, adding 13,150,000 shares (total reserve now 18,542,144).","Amended charter to provide officer exculpation under Delaware law; 190.2M for, 22.1M against.","All nine director nominees elected, including Samuel N. Hazen and Thomas F. Frist III, with >84% support.","Non-management director compensation updated: $130K annual cash retainer, $220K annual equity award, plus committee chair retainers.","Stockholder proposals on golden parachutes, patient safety committee charter, and acquisition strategy all rejected."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":166866,"accession_number":"0000950170-25-058334","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q1 revenue $18.3B, EPS $6.45, adjusted EBITDA $3.73B, reaffirms guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $18.321B (+5.7% YoY); net income $1.610B, diluted EPS $6.45 (vs $5.93 prior year).","Adjusted EBITDA $3.733B (+11.3% YoY); same facility admissions +2.6%, ER visits +4.0%.","Cash from ops $1.651B (down from $2.469B); repurchased 7.762M shares for $2.506B.","Declared quarterly dividend $0.72/share, payable June 30 to holders of record June 16.","Reaffirmed full-year 2025 guidance ranges including Adjusted EBITDA and EPS."],"consensus_eps_estimate":null,"consensus_eps_actual":6.45,"consensus_revenue_estimate":null,"consensus_revenue_actual":18321000000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184271,"accession_number":"0001193125-25-033430","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-02-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"HCA director Crofton to retire at April 2025 annual meeting; exec incentive program adopted","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Meg G. Crofton to retire from HCA board effective April 24, 2025 annual meeting.","Compensation Committee adopted 2025 Executive Officer Performance Excellence Program for named execs.","CEO Hazen target award 175% of base salary; CFO Marks and COO Foster 125%.","Awards weighted 80% EBITDA and 20% quality metrics (HAI, sepsis, mortality, care experience).","EBITDA portion: threshold 25%, target 100%, max 200% of target; quality metrics similar but no payout if EBITDA <90% of target."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184270,"accession_number":"0001193125-25-031999","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["1.01","2.03","8.01","9.01"],"status":"ready","headline":"HCA Inc. issues $5.25B of senior notes across six tranches maturing 2028-2055","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Total $5.25B: $700M 5.000% notes due 2028, $300M floating-rate notes due 2028, $750M 5.250% due 2030.","Additional $750M 5.500% due 2032, $1.5B 5.750% due 2035, and $1.25B 6.200% due 2055.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by HCA Healthcare on a senior unsecured basis.","Issued under shelf registration; proceeds for general corporate purposes (per typical use).","Underwriting agreement with BofA, Barclays, Citi, J.P. Morgan, Mizuho, Wells Fargo dated Feb 18, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184269,"accession_number":"0001193125-25-030833","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-02-20T23:59:59+00:00","items":["1.01","1.02","2.03","9.01"],"status":"ready","headline":"HCA enters $8.0B unsecured revolver, terminates secured credit facilities","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $8.0B senior unsecured revolving credit facility with 5-year maturity dated Feb 20, 2025.","Borrower used facility to repay $3.5B revolver and $1.238B term loan under prior secured facilities.","Interest rate initially Term SOFR + 1.250% plus 0.10% credit spread adjustment.","Financial covenant: leverage ratio ≤ 4.50:1 (step-up to 5.00:1 after material acquisition).","Proceeds to be used for general corporate purposes; facility is unsecured and not guaranteed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184268,"accession_number":"0001193125-25-028231","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Inc. proposes public offering of senior notes; plans $8B unsecured credit facility to replace secured facilities","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["HCA subsidiary HCA Inc. proposes offering of senior notes; final terms (maturity, rate, amount) depend on market conditions.","Issuer intends to refinance $3.5B cash flow and $4.5B ABL secured credit facilities with new $8B senior unsecured revolving credit facility.","New facility has 5-year term, leverage covenant of 4.50:1.00 (step-up to 5.00 after material acquisition), and initial rate of Term SOFR + 1.250% plus 0.10% credit spread.","Net proceeds from note offering will be used for general corporate purposes, which may include repaying $2.95B ABL borrowings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":184267,"accession_number":"0000950170-25-008608","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2025-01-24T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q4 revenue $18.3B, EPS $5.63; 2025 EPS guidance $24.05-$25.85; $10B buyback authorized","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $18.285B (+5.7% YoY); net income $1.438B ($5.63 diluted EPS) vs $1.607B ($5.93) in 4Q23; includes $0.60/sh hurricane impact.","Adjusted EBITDA Q4 $3.712B vs $3.618B; same-facility admissions +3.0%, equivalent admissions +3.1%.","Full year 2024 revenue $70.6B, net income $5.76B ($22.00 EPS) vs $5.24B ($18.97) in 2023; Adjusted EBITDA $13.88B.","2025 guidance: revenue $72.8-$75.8B, net income $5.85-$6.29B, EPS $24.05-$25.85, capex $5.0-$5.2B.","Board authorized $10B share repurchase; quarterly dividend $0.72/share payable Mar 31 to record Mar 17."],"consensus_eps_estimate":null,"consensus_eps_actual":22.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":70603000000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":200870,"accession_number":"0000950170-24-117215","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-10-25T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Healthcare Q3 2024 revenue $17.49B, EPS $4.88; reaffirms FY guidance but sees lower half due to hurricanes","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $17.487B (up 7.9% YoY), net income $1.270B (up 17.7%), diluted EPS $4.88 vs $3.91.","Adjusted EBITDA $3.267B, up from $2.880B; same facility admissions +4.5%, ER visits +4.6%.","Hurricane Helene impact $50M ($0.15/sh) in Q3; Q4 estimate $200-300M ($0.60-0.90/sh) from Helene and Milton.","Reaffirmed FY 2024 guidance, expects results in lower half; capex now ~$5B.","Declared quarterly dividend $0.66 per share payable Dec 27, 2024 to holders of record Dec 13, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":16.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":52318000000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216861,"accession_number":"0001193125-24-198927","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-08-12T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"HCA Healthcare issues $3B in senior notes across three tranches with rates 5.45%-5.95%","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$3B total: $750M 5.45% notes due 2031 (now $1.75B total), $1.25B 5.45% notes due 2034, $1B 5.95% notes due 2054.","Notes are senior unsecured obligations of HCA Inc., fully guaranteed by HCA Healthcare.","Interest payable semi-annually; first payments Oct 2024 (2031) and Mar 2025 (2034/2054).","Optional redemption permitted; change-of-control repurchase at 101% of principal plus accrued interest.","Indentures include customary covenants limiting liens, sale-leaseback, and mergers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216860,"accession_number":"0001193125-24-197060","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"HCA Healthcare issues $3B senior notes in three tranches; 2031 notes fungible with existing","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$750M of 5.450% Senior Notes due 2031, issued as additional notes under existing indenture and fungible with prior $1B issue.","$1.25B of 5.450% Senior Notes due 2034; $1B of 5.950% Senior Notes due 2054.","Notes are senior unsecured obligations guaranteed by HCA Healthcare, Inc. (parent).","Issuance via underwriting agreement with Citigroup, BofA, J.P. Morgan, and Wells Fargo as representatives."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":216859,"accession_number":"0001193125-24-182591","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q2 2024 rev $17.49B, EPS $5.53, raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $17.492B (+10.3% YoY); net income $1.461B ($5.53 diluted EPS) vs $1.193B ($4.29).","Adjusted EBITDA $3.550B (+16.2% YoY); same facility admissions +5.8%, ER visits +5.5%.","FY2024 guidance raised: rev $69.75-71.75B (prev $67.75-70.25B), EPS $21.60-22.80 (prev $19.70-21.20).","Board declared quarterly dividend $0.66/share, payable Sept 30, record Sept 16.","Repurchased 4.217M shares at $1.367B in Q2; $4.228B remaining under buyback authorization."],"consensus_eps_estimate":null,"consensus_eps_actual":11.47,"consensus_revenue_estimate":null,"consensus_revenue_actual":34831000000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236596,"accession_number":"0001193125-24-125204","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-04-30T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"HCA Healthcare CFO William Rutherford to retire May 1; Christopher Wyatt named principal accounting officer","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William B. Rutherford retires as EVP/CFO effective May 1, 2024; Christopher Wyatt succeeds as principal accounting officer.","Annual meeting elects all 10 director nominees and ratifies Ernst & Young as auditor for 2024.","Say-on-pay advisory vote approved with 217M votes for and 13.5M against; one-year frequency adopted.","Stockholder proposals on abortion risk, patient feedback, and maternal health outcomes all defeated by wide margins."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":236595,"accession_number":"0001193125-24-115857","cik":860730,"company_name":"HCA Healthcare, Inc.","ticker":"HCA","form_type":"8-K","filed_at":"2024-04-26T23:59:59+00:00","items":["2.02","7.01","8.01","9.01"],"status":"ready","headline":"HCA Q1 revenue up 11% to $17.34B, EPS $5.93; reaffirms FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $17.339B (+11.2% YoY); net income $1.591B ($5.93 diluted EPS) vs $1.363B ($4.85).","Adjusted EBITDA $3.353B; same facility admissions +6.2%, equivalent admissions +5.2%.","Cash from operations $2.469B; repurchased 3.894M shares for $1.180B; $5.595B remaining.","Board declared $0.66/share dividend, payable June 28 to holders of record June 14.","Reaffirmed 2024 guidance; includes $201M gain on sale of California hospital."],"consensus_eps_estimate":null,"consensus_eps_actual":5.93,"consensus_revenue_estimate":null,"consensus_revenue_actual":17339000000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":86994479752.4973,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}